Abstract
Long known for its anti-nociceptive effects, the opioid β-endorphin is also reported to have rewarding and reinforcing properties and to be involved in stress response. In this manuscript we summarize the present neurobiological and behavioral evidence regarding the role of β-endorphin in stress-related psychiatric disorders, depression and PTSD. There is existing data that support the importance of β-endorphin neurotransmission in mediating depression. As for PTSD, however, the data is thus far circumstantial. The studies described herein used diverse techniques, such as biochemical measurements of β-endorphin in various brain sites and behavioral monitoring, in two animal models of depression and PTSD. We suggest that the pathways for stress-related psychiatric disorders, depression and PTSD, converge to a common pathway in which β-endorphin is a modulating element of distress. This may occur its interaction with the mesolimbic monoaminergic system and also by its interesting effects on learning and memory. The possible involvement of β- endorphin in the process of stress-related psychiatric disorders, depression and PTSD, is discussed.
Keywords: Anxiety, depression, post-traumatic stress disorder (PTSD), opioids
Current Drug Targets
Title: The β-Endorphin Role in Stress-Related Psychiatric Disorders
Volume: 10 Issue: 11
Author(s): Avia Merenlender-Wagner, Yahav Dikshtein and Gal Yadid
Affiliation:
Keywords: Anxiety, depression, post-traumatic stress disorder (PTSD), opioids
Abstract: Long known for its anti-nociceptive effects, the opioid β-endorphin is also reported to have rewarding and reinforcing properties and to be involved in stress response. In this manuscript we summarize the present neurobiological and behavioral evidence regarding the role of β-endorphin in stress-related psychiatric disorders, depression and PTSD. There is existing data that support the importance of β-endorphin neurotransmission in mediating depression. As for PTSD, however, the data is thus far circumstantial. The studies described herein used diverse techniques, such as biochemical measurements of β-endorphin in various brain sites and behavioral monitoring, in two animal models of depression and PTSD. We suggest that the pathways for stress-related psychiatric disorders, depression and PTSD, converge to a common pathway in which β-endorphin is a modulating element of distress. This may occur its interaction with the mesolimbic monoaminergic system and also by its interesting effects on learning and memory. The possible involvement of β- endorphin in the process of stress-related psychiatric disorders, depression and PTSD, is discussed.
Export Options
About this article
Cite this article as:
Merenlender-Wagner Avia, Dikshtein Yahav and Yadid Gal, The β-Endorphin Role in Stress-Related Psychiatric Disorders, Current Drug Targets 2009; 10 (11) . https://dx.doi.org/10.2174/138945009789735147
DOI https://dx.doi.org/10.2174/138945009789735147 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effect of Polyherbal Drug Majun Falasfa on the Transgenic Drosophila
Model of Parkinson’s Disease
Current Traditional Medicine Synthesis and Evaluation of the Anticonvulsant Activities of New 5-substitued-[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one Derivatives
Letters in Drug Design & Discovery Association between Periodontal Health Status and Cognitive Abilitie s. The Role of Cytokine Profile and Systemic Inflammation
Current Alzheimer Research Improved Prediction of Protein Ligand-Binding Sites Using Random Forests
Protein & Peptide Letters PPARγ Activation Improves the Molecular and Functional Components of Ito Remodeling by Angiotensin II
Current Pharmaceutical Design Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives
Current Stem Cell Research & Therapy Editorial: Can Hangover Immunity be Really Claimed?
Current Drug Abuse Reviews A Brief Overview of Tyrosine Hydroxylase and α-Synuclein in the Parkinsonian Brain
CNS & Neurological Disorders - Drug Targets New Route to Synthesize Fluorine Substituted Lamotrigine Drug Analogues as an Anti-Inflammatory Agent
Current Organic Synthesis Concurrent Estimation of Gabapentin and Nortriptyline Hydrochloride in their Combined Dosage Form Using OPA-β-Mercaptoethanol Derivatization by Spectrophotometric and Spectrofluorimetric Methods
Current Pharmaceutical Analysis Drug Screening for Huntingtons Disease and other Neurodegenerative Disorders
Current Molecular Pharmacology Meet Our Section Editor
Current Drug Discovery Technologies Interferon-γ-Induced Conversion of Tryptophan: Immunologic and Neuropsychiatric Aspects
Current Medicinal Chemistry Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells
Current Pharmacogenomics and Personalized Medicine Quantitative Electroencephalogram (EEG) in Insomnia: A New Window on Pathophysiological Mechanisms
Current Pharmaceutical Design High Sensitivity C-Reactive Protein (hsCRP): A New Biochemical Marker of Atherosclerotic Vascular Disease
Current Cardiology Reviews Targeting Glia Cells: Novel Perspectives for the Treatment of Neuropsychiatric Diseases
Current Neuropharmacology P-glycoprotein Inhibition: The Past, the Present and the Future
Current Drug Metabolism Mapping the Corrosion Behavior of AZ91D Magnesium Alloy: Influence of Chloride Concentration and Potentiostatic Polarization
Innovations in Corrosion and Materials Science (Discontinued) Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Current Status and Future Perspectives in the Development of Novel Irreversible Inhibitors for the Treatment of Mutant Non-small Cell Lung Cancer
Current Pharmaceutical Design